Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FENC | FENNEC PHARMACEUTICALS INC | $192.35M | $7.04 | $16.00 | 127.27% | Buy | 2 | 22.47% | 159.90% | N/A | N/A | ||||
| SRPT | SAREPTA THERAPEUTICS INC | $12.42B | $131.38 | $165.39 | 25.88% | Strong Buy | 13 | 28.20% | 153.38% | N/A | N/A | ||||
| TGTX | TG THERAPEUTICS INC | $2.55B | $16.48 | $31.20 | 89.32% | Strong Buy | 5 | 28.50% | 61.87% | N/A | N/A | ||||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.65B | $29.03 | $39.80 | 37.10% | Hold | 5 | 15.57% | 38.33% | N/A | N/A | ||||
| INCY | INCYTE CORP | $12.82B | $57.10 | $74.92 | 31.21% | Buy | 13 | 10.20% | 41.93% | N/A | N/A | ||||
| CORT | CORCEPT THERAPEUTICS INC | $2.92B | $28.09 | $40.67 | 44.77% | Strong Buy | 3 | 13.42% | 24.89% | N/A | N/A | ||||
| CPRX | CATALYST PHARMACEUTICALS INC | $1.95B | $16.49 | $27.80 | 68.59% | Strong Buy | 5 | 15.07% | 20.89% | N/A | N/A | ||||
| HALO | HALOZYME THERAPEUTICS INC | $5.69B | $44.71 | $54.00 | 20.78% | Buy | 6 | 14.41% | 41.76% | N/A | N/A | ||||
| RPRX | ROYALTY PHARMA PLC | $16.29B | $27.27 | $43.33 | 58.90% | Strong Buy | 3 | 14.11% | 60.66% | N/A | N/A | ||||
| GMAB | GENMAB A | $19.82B | $29.98 | $45.00 | 50.10% | Buy | 4 | 18.93% | 37.91% | N/A | N/A | ||||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $14.73B | $77.56 | $99.09 | 27.76% | Buy | 11 | 11.22% | 81.99% | N/A | N/A | ||||
| MNKD | MANNKIND CORP | $1.25B | $4.59 | $7.00 | 52.51% | Strong Buy | 2 | 16.05% | 132.08% | N/A | N/A | ||||
| EXEL | EXELIXIS INC | $6.09B | $20.91 | $26.78 | 28.06% | Buy | 9 | 7.83% | 56.43% | N/A | N/A | ||||
| PBYI | PUMA BIOTECHNOLOGY INC | $197.54M | $4.10 | $7.00 | 70.94% | Buy | 1 | 2.20% | 67.87% | N/A | N/A | ||||
| BNTX | BIONTECH SE | $21.54B | $90.61 | $111.88 | 23.47% | Hold | 8 | 0.97% | 175.42% | N/A | N/A | ||||
| TECH | BIO-TECHNE CORP | $13.21B | $83.81 | $80.71 | -3.69% | Strong Buy | 7 | 6.18% | 33.92% | N/A | N/A | ||||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.87B | $108.99 | $190.55 | 74.83% | Strong Buy | 11 | 6.61% | 77.12% | N/A | N/A | ||||
| MDXG | MIMEDX GROUP INC | $1.15B | $7.80 | $12.33 | 58.12% | Strong Buy | 3 | 14.09% | 14.96% | N/A | N/A | ||||
| NVO | NOVO NORDISK A S | $594.82B | $131.89 | $133.00 | 0.84% | Strong Buy | 6 | 19.78% | 2.84% | N/A | N/A | ||||
| REGN | REGENERON PHARMACEUTICALS INC | $108.23B | $982.29 | $1.04k | 6.00% | Buy | 14 | 7.20% | 5.74% | N/A | N/A | ||||
| UTHR | UNITED THERAPEUTICS CORP | $12.16B | $274.26 | $317.17 | 15.64% | Buy | 6 | 7.12% | 6.59% | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.